Help Ensure Safe Transitions of Care for Pulmonary Hypertension Patients

March 2017

It's getting harder to keep up with medications for pulmonary hypertension...especially with more patients on combination therapy.

Help ensure safe transitions of care for these patients.

Continue most meds on admission. Avoid interruptions in prostacyclin therapy...especially IV epoprostenol (Flolan, Veletri, etc) and treprostinil (Remodulin) continuous infusions. Abruptly stopping these can lead to life-threatening rebound pulmonary hypertension.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote